1
|
Ma Y, Gao L, Tian Y, Chen P, Yang J, Zhang L. Advanced biomaterials in cell preservation: Hypothermic preservation and cryopreservation. Acta Biomater 2021; 131:97-116. [PMID: 34242810 DOI: 10.1016/j.actbio.2021.07.001] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2021] [Revised: 06/29/2021] [Accepted: 07/01/2021] [Indexed: 02/07/2023]
Abstract
Cell-based medicine has made great advances in clinical diagnosis and therapy for various refractory diseases, inducing a growing demand for cell preservation as support technology. However, the bottleneck problems in cell preservation include low efficiency and poor biocompatibility of traditional protectants. In this review, cell preservation technologies are categorized according to storage conditions: hypothermic preservation at 1 °C~35 °C to maintain short-term cell viability that is useful in cell diagnosis and transport, while cryopreservation at -196 °C~-80 °C to maintain long-term cell viability that provides opportunities for therapeutic cell product storage. Firstly, the background and developmental history of the protectants used in the two preservation technologies are briefly introduced. Secondly, the progress in different cellular protection mechanisms for advanced biomaterials are discussed in two preservation technologies. In hypothermic preservation, the hypothermia-induced and extracellular matrix-loss injuries to cells are comprehensively summarized, as well as the recent biomaterials dependent on regulation of cellular ATP level, stabilization of cellular membrane, balance of antioxidant defense system, and supply of mimetic ECM to prolong cell longevity are provided. In cryopreservation, cellular injuries and advanced biomaterials that can protect cells from osmotic or ice injury, and alleviate oxidative stress to allow cell survival are concluded. Last, an insight into the perspectives and challenges of this technology is provided. We envision advanced biocompatible materials for highly efficient cell preservation as critical in future developments and trends to support cell-based medicine. STATEMENT OF SIGNIFICANCE: Cell preservation technologies present a critical role in cell-based applications, and more efficient biocompatible protectants are highly required. This review categorizes cell preservation technologies into hypothermic preservation and cryopreservation according to their storage conditions, and comprehensively reviews the recently advanced biomaterials related. The background, development, and cellular protective mechanisms of these two preservation technologies are respectively introduced and summarized. Moreover, the differences, connections, individual demands of these two technologies are also provided and discussed.
Collapse
Affiliation(s)
- Yiming Ma
- Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300350, PR China; Frontier Technology Research Institute, Tianjin University, Tianjin 300350, PR China
| | - Lei Gao
- Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300350, PR China; Frontier Technology Research Institute, Tianjin University, Tianjin 300350, PR China
| | - Yunqing Tian
- Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300350, PR China; Frontier Technology Research Institute, Tianjin University, Tianjin 300350, PR China
| | - Pengguang Chen
- Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300350, PR China; Frontier Technology Research Institute, Tianjin University, Tianjin 300350, PR China
| | - Jing Yang
- Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300350, PR China; Frontier Technology Research Institute, Tianjin University, Tianjin 300350, PR China.
| | - Lei Zhang
- Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300350, PR China; Frontier Technology Research Institute, Tianjin University, Tianjin 300350, PR China.
| |
Collapse
|
2
|
Rossnagl S, von Au A, Vasel M, Cecchini AG, Nakchbandi IA. Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer. PLoS One 2014; 9:e94922. [PMID: 24740307 PMCID: PMC3989235 DOI: 10.1371/journal.pone.0094922] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2013] [Accepted: 03/21/2014] [Indexed: 12/27/2022] Open
Abstract
Cancer is associated with increased fracture risk, due either to metastasis or associated osteoporosis. After a fracture, blood clots form. Because proteins of the coagulation cascade and activated platelets promote cancer development, a fracture in patients with cancer often raises the question whether it is a pathologic fracture or whether the fracture itself might promote the formation of metastatic lesions. We therefore examined whether blood clot formation results in increased metastasis in a murine model of experimental breast cancer metastasis. For this purpose, a clot was surgically induced in the bone marrow of the left tibia of immundeficient mice. Either one minute prior to or five minutes after clot induction, human cancer cells were introduced in the circulation by intracardiac injection. The number of cancer cells that homed to the intervention site was determined by quantitative real-time PCR and flow cytometry. Metastasis formation and longitudinal growth were evaluated by bioluminescence imaging. The number of cancer cells that homed to the intervention site after 24 hours was similar to the number of cells in the opposite tibia that did not undergo clot induction. This effect was confirmed using two more cancer cell lines. Furthermore, no difference in the number of macroscopic lesions or their growth could be detected. In the control group 72% developed a lesion in the left tibia. In the experimental groups with clot formation 79% and 65% developed lesions in the left tibia (p = ns when comparing each experimental group with the controls). Survival was similar too. In summary, the growth factors accumulating in a clot/hematoma are neither enough to promote cancer cell homing nor support growth in an experimental model of breast cancer bone metastasis. This suggests that blood clot formation, as occurs in traumatic fractures, surgical interventions, and bruises, does not increase the risk of metastasis formation.
Collapse
Affiliation(s)
- Stephanie Rossnagl
- Max-Planck Institute of Biochemistry, Martinsried, Germany
- Institute of Immunology, University of Heidelberg, Heidelberg, Germany
| | - Anja von Au
- Max-Planck Institute of Biochemistry, Martinsried, Germany
- Institute of Immunology, University of Heidelberg, Heidelberg, Germany
| | - Matthaeus Vasel
- Max-Planck Institute of Biochemistry, Martinsried, Germany
- Institute of Immunology, University of Heidelberg, Heidelberg, Germany
| | | | - Inaam A. Nakchbandi
- Max-Planck Institute of Biochemistry, Martinsried, Germany
- Institute of Immunology, University of Heidelberg, Heidelberg, Germany
- * E-mail:
| |
Collapse
|
3
|
Pritsch K, Courty PE, Churin JL, Cloutier-Hurteau B, Ali MA, Damon C, Duchemin M, Egli S, Ernst J, Fraissinet-Tachet L, Kuhar F, Legname E, Marmeisse R, Müller A, Nikolova P, Peter M, Plassard C, Richard F, Schloter M, Selosse MA, Franc A, Garbaye J. Optimized assay and storage conditions for enzyme activity profiling of ectomycorrhizae. MYCORRHIZA 2011; 21:589-600. [PMID: 21344212 DOI: 10.1007/s00572-011-0364-4] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2010] [Accepted: 01/28/2011] [Indexed: 05/30/2023]
Abstract
The aim of a joint effort by different research teams was to provide an improved procedure for enzyme activity profiling of field-sampled ectomycorrhizae, including recommendations on the best conditions and maximum duration for storage of ectomycorrhizal samples. A more simplified and efficient protocol compared to formerly published procedures was achieved by using manufactured 96-filter plates in combination with a vacuum manifold and by optimizing incubation times. Major improvements were achieved by performing the series of eight enzyme assays with a single series of root samples instead of two series, reducing the time needed for sample preparation, minimizing error-prone steps such as pipetting and morphotyping, and facilitating subsequent DNA analyses due to the reduced sequencing effort. The best preservation of samples proved to be storage in soil at 4-6 °C in the form of undisturbed soil cores containing roots. Enzyme activities were maintained for up to 4 weeks under these conditions. Short-term storage of washed roots and ectomycorrhizal tips overnight in water did not cause substantial changes in enzyme activity profiles. No optimal means for longer-term storage by freezing at -20 °C or storage in 100% ethanol were recommended.
Collapse
Affiliation(s)
- Karin Pritsch
- Institute of Soil Ecology, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany.
| | - Pierre Emanuel Courty
- UMR 1136, Interactions Arbres Micro-organismes, Centre INRA de Nancy, 54280, Champenoux, France
- Botanical Institute, University of Basel, 4056, Basel, Switzerland
| | - Jean-Louis Churin
- UMR 1136, Interactions Arbres Micro-organismes, Centre INRA de Nancy, 54280, Champenoux, France
| | - Benoit Cloutier-Hurteau
- UMR 1222, Ecologie Fonctionelle et Biogéochimie des Sols, INRA/IRD/SupAgro, 34060, Montpellier Cedex 01, France
| | - Muhammad Arif Ali
- UMR 1222, Ecologie Fonctionelle et Biogéochimie des Sols, INRA/IRD/SupAgro, 34060, Montpellier Cedex 01, France
| | - Coralie Damon
- UMR CNRS 5557 d'Ecologie Microbienne, Université de Lyon, Université Lyon 1, 69622, Villeurbanne Cedex, France
| | - Myriam Duchemin
- UMR 1222, Ecologie Fonctionelle et Biogéochimie des Sols, INRA/IRD/SupAgro, 34060, Montpellier Cedex 01, France
| | - Simon Egli
- Swiss Federal Research Institute WSL, 8903, Birmensdorf, Switzerland
| | - Jana Ernst
- Institute of Soil Ecology, Terrestrial Ecogenetics, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany
| | - Laurence Fraissinet-Tachet
- UMR CNRS 5557 d'Ecologie Microbienne, Université de Lyon, Université Lyon 1, 69622, Villeurbanne Cedex, France
| | - Francisco Kuhar
- Biodiversidad y Biología Experimental, CABA, Universidad de Buenos Aires, Buenos Aires, 1428, Argentina
- Institute of Soil Ecology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany
| | - Elvira Legname
- UMR 1222, Ecologie Fonctionelle et Biogéochimie des Sols, INRA/IRD/SupAgro, 34060, Montpellier Cedex 01, France
| | - Roland Marmeisse
- UMR CNRS 5557 d'Ecologie Microbienne, Université de Lyon, Université Lyon 1, 69622, Villeurbanne Cedex, France
| | - Alex Müller
- Swiss Federal Research Institute WSL, 8903, Birmensdorf, Switzerland
| | - Petia Nikolova
- Institute of Soil Ecology, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany
| | - Martina Peter
- Swiss Federal Research Institute WSL, 8903, Birmensdorf, Switzerland
| | - Claude Plassard
- UMR 1222, Ecologie Fonctionelle et Biogéochimie des Sols, INRA/IRD/SupAgro, 34060, Montpellier Cedex 01, France
| | - Franck Richard
- UMR 5175, Centre d'Ecologie Fonctionnelle et Evolutive, 34293, Montpellier 5, France
| | - Michael Schloter
- Institute of Soil Ecology, Terrestrial Ecogenetics, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany
| | - Marc-André Selosse
- UMR 5175, Centre d'Ecologie Fonctionnelle et Evolutive, 34293, Montpellier 5, France
| | - Alain Franc
- UMR Biodivers Genes & Communautes, INRA Pierroton, 33612, Cestas, France
| | - Jean Garbaye
- UMR 1136, Interactions Arbres Micro-organismes, Centre INRA de Nancy, 54280, Champenoux, France
| |
Collapse
|